A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors (Q33413739)

26 July 2017

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors (English)

1 reference

26 July 2017

Colin D Weekes

1

1 reference

26 July 2017

Muralidhar Beeram

2

1 reference

26 July 2017

Anthony W Tolcher

3

1 reference

26 July 2017

Kyriakos P Papadopoulos

4

1 reference

26 July 2017

Lia Gore

5

1 reference

26 July 2017

Priti Hegde

6

1 reference

26 July 2017

Yan Xin

7

1 reference

26 July 2017

Ron Yu

8

1 reference

26 July 2017

L Mason Shih

9

1 reference

26 July 2017

Hong Xiang

10

1 reference

26 July 2017

Rainer K Brachmann

11

1 reference

26 July 2017

Amita Patnaik

12

1 reference

26 July 2017

7 March 2014

1 reference

Investigational New Drugs

26 July 2017

1 reference

26 July 2017

32

1 reference

26 July 2017

653-660

1 reference

26 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10637-014-0071-z

26 July 2017

0 references

cites work

Connecting vascular and nervous system development: angiogenesis and the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Neuropilin is a receptor for the axonal chemorepellent Semaphorin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Neuropilins: a new target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Neuropilins in neoplasms: expression, regulation, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Anti-neuropilin-1 (MNRP1685A): unexpected pharmacokinetic differences across species, from preclinical models to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel antiangiogenesis agent, in two phase I trials in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Monoclonal antibody-induced cytokine-release syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

IL-1 pathways in inflammation and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

Neuropilins: structure, function and role in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0071-Z

A requirement for neuropilin-1 in embryonic vessel formation.

21 January 2018

1 reference

12 December 2020

Optimal first-line treatment in ovarian cancer

1 reference

12 December 2020

Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity

1 reference

12 December 2020

A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors

1 reference

12 December 2020

IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction--a comparative study of human clinical-applicable DC

1 reference

12 December 2020

10.1007/S10637-014-0071-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference